Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin in Subarachnoid Hemorrhage (ISCHEMIA)
NCT04507178Phase 2Recruiting
- Sponsor
- University of Amsterdam
- Start
- Feb 2022
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nadroparin in aneurysmal subarachnoid hemorrhage (SAH), sponsored by University of Amsterdam. Started Feb 2022; status: recruiting.
02
Drugs
nadroparin
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04507178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507178.